Price: $ 1295
BMI View: A number of negative developments this quarter have led us to downgrade our pharmaceutical and healthcare forecasts. The establishment of a 'preferred drugs' list and implementation of the Health (Pricing and Supply of Medical Goods) Bill shows the government's determination to exact cost savings from pharmaceutical companies. While these initiatives will benefit generic drugmakers, the Irish Pharmacy Union has voiced concerns that current medicine shortages will be exacerbated as a result. Headline Expenditure Projections ? Pharmaceuticals: EUR2.17bn (US$2.75bn) in 2012 to EUR2.02bn (US$2.69bn) in 2013; -6.7 % in local currency terms and -2.2% in US dollar terms. Forecast downgraded slightly from previous quarter. ? Healthcare: EUR14.02bn (US$17.81bn) in 2012 to EUR13.49bn (US$17. ...
Complete report details with Table of Contents and more @ http://www.marketreportsonline.com/279662.html
No comments:
Post a Comment